Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Nafiverine is a new antispasmodic. The effectiveness of an intramuscular administration of nafiverine was comparable to that of an intravenous administration.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | Nafiverine is a new antispasmodic. The effectiveness of an intramuscular administration of nafiverine was comparable to that of an intravenous administration. |
別名 | UNII-WLT400RC9Q, Nafiverina, Nafiverinum, EINECS 225-766-5 |
分子量 | 538.68 |
分子式 | C34H38N2O4 |
CAS No. | 5061-22-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Nafiverine 5061-22-3 UNII-WLT400RC9Q Nafiverina Nafiverinum EINECS 225-766-5 Inhibitor inhibitor inhibit